Interestingly, the HLA-DRB1 DMR was identified using a different method from that described by Maltby et al. When we investigated the gene expression of HLA-DRB1, we observed that while hypomethylation was present in MS patients compared to controls, this gene has decreased expression in MS patients. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.